Avodart (Dutasteride) Cost in New Hampshire: 2026 Prices, Insurance, and Savings

Brand vs. Generic Dutasteride Pricing in New Hampshire

The single biggest factor in what you pay is whether you fill brand-name Avodart or a generic equivalent. GSK's branded Avodart carries a manufacturer list price near $290 per month for a 30-count supply of 0.5 mg soft-gelatin capsules. Generic dutasteride, available since FDA exclusivity expired in 2015, averages about $25 per month cash-pay across New Hampshire retail pharmacies in 2026.

That price gap matters. A patient paying out of pocket for brand Avodart would spend roughly $3,480 per year versus $300 per year on the generic. The FDA considers approved generics therapeutically equivalent to their brand-name counterparts, meaning the 0.5 mg generic capsule delivers the same dutasteride exposure. For benign prostatic hyperplasia, the indication for which the FDA approved dutasteride in 2001, switching to generic produces no expected change in clinical outcomes.

Pricing can vary by pharmacy within the state. Chains like CVS, Walgreens, and Rite Aid in Manchester, Nashua, and Concord may quote different prices depending on their wholesale contracts. Independent pharmacies sometimes undercut chains. Requesting a price check at two or three locations, or running a search through a discount-card aggregator, typically reveals a spread of $8 to $30 per month for the generic.

New Hampshire Medicaid and Dutasteride Coverage

New Hampshire Medicaid does not cover Avodart or generic dutasteride on its preferred drug list as of 2026. Patients enrolled in the state's Medicaid managed care programs (administered through AmeriHealth Caritas and Well Sense Health Plan) will find dutasteride excluded or subject to a non-preferred prior authorization process that is rarely approved.

This exclusion aligns with a broader pattern. Many state Medicaid formularies prefer tamsulosin (Flomax) or finasteride as first-line 5-alpha reductase inhibitor therapy for BPH, largely because finasteride entered the generic market earlier and accumulated a longer track record. The AUA guidelines on management of BPH list both finasteride and dutasteride as options for men with prostates larger than 30 to 40 grams, but do not preferentially recommend one over the other. Cost, not efficacy, drives most formulary decisions.

For Medicaid-enrolled patients who specifically need dutasteride (for example, those who tried finasteride without adequate symptom improvement), a prescriber can submit a prior authorization with documentation of clinical necessity per CMS rebate requirements. Approval rates for these appeals vary, and denials can be challenged through the state's fair-hearing process.

Insurance Coverage for Avodart in New Hampshire

Commercial insurance plans in New Hampshire handle dutasteride differently from Medicaid. Most employer-sponsored and marketplace plans (Anthem, Ambetter, Harvard Pilgrim, Cigna) include generic dutasteride on their formularies, typically at a Tier 2 or Tier 3 copay. Expect $10 to $35 per month depending on your plan's pharmacy benefit structure.

Brand Avodart, by contrast, sits on Tier 3 or the non-preferred brand tier for almost every commercial plan. Copays for brand-name dispensing can run $50 to $75 per month even with insurance, making the generic a consistently better financial choice.

Medicare Part D plans in New Hampshire generally cover generic dutasteride. The CMS Part D formulary finder lets beneficiaries search coverage by ZIP code. Most plans place generic dutasteride in Tier 1 or Tier 2 with copays between $3 and $15. During the coverage gap (donut hole) phase, beneficiaries pay 25% of the negotiated price, which on a $25 generic amounts to roughly $6 per month.

Before filling a prescription, call the number on your insurance card and ask three questions: is generic dutasteride covered, what tier is it on, and does it require prior authorization? Those answers take five minutes and can prevent a surprise bill at the pharmacy counter.

Compounded Dutasteride in New Hampshire

Compounded dutasteride is legal and available in New Hampshire through 503A-licensed pharmacies operating under prescriber-specific prescriptions. These pharmacies compound patient-specific preparations that are not commercially available in the exact form prescribed.

The most common compounded formulation is a topical dutasteride solution (often 0.1% to 0.25%) for scalp application in androgenetic alopecia. Compounded oral capsules at 0.5 mg also exist but offer no advantage over the commercially available generic capsule. Expect compounded preparations to cost approximately $40 per month, which is more expensive than the retail generic but may be relevant for patients seeking a topical route.

A few points of caution. Compounded drugs are not FDA-approved and not evaluated for safety or efficacy the same way as approved products. Quality can vary between compounding pharmacies. The New Hampshire Board of Pharmacy oversees 503A facilities within the state, but patients should confirm that their compounding pharmacy holds current licensure and follows USP 795/800 standards. Topical dutasteride has shown promise in small studies. Saceda-Corralo et al. (2022) reported measurable improvements in hair density with topical dutasteride, though large randomized trials have not yet been completed.

Off-Label Use: Dutasteride for Hair Loss

Dutasteride is FDA-approved only for BPH, but prescribers in New Hampshire (and nationally) commonly prescribe it off-label for male androgenetic alopecia. The pharmacologic rationale is straightforward: dutasteride inhibits both type I and type II 5-alpha reductase isoenzymes, while finasteride inhibits only type II. This dual inhibition produces a greater reduction in serum and scalp dihydrotestosterone (DHT).

The clinical evidence supports this mechanism. Eun et al. (2010) conducted a randomized controlled trial comparing dutasteride 0.5 mg daily to finasteride 1 mg daily in 90 men with androgenetic alopecia. At 24 weeks, the dutasteride group showed significantly greater increases in total and terminal hair counts. A larger phase III trial by Olsen et al. (2006) (N=416) demonstrated dose-dependent improvements in target-area hair count with dutasteride 0.1, 0.5, and 2.5 mg daily versus placebo at 24 weeks.

Because hair-loss prescribing is off-label, insurance plans do not cover dutasteride for this indication. Patients using dutasteride for alopecia pay the full cash price, which at $25 per month generic is still accessible. The AUA and AAD have not issued formal guidelines endorsing dutasteride for alopecia, though many dermatologists consider it a reasonable second-line option after finasteride.

Telehealth Access to Dutasteride in New Hampshire

New Hampshire permits telehealth prescribing of dutasteride. Following state telehealth parity laws updated in 2023, prescribers licensed in New Hampshire can evaluate patients via synchronous video or audio visits and prescribe schedule-unscheduled medications including dutasteride.

Telehealth platforms that operate in New Hampshire (HealthRX, Hims, Keeps, and others) can prescribe generic dutasteride for BPH or off-label for hair loss, and either send the prescription to a local pharmacy or ship medication directly. Shipped medication prices through telehealth platforms range from $20 to $50 per month depending on the platform and whether they use in-house or partner pharmacies.

For BPH patients, a baseline PSA and digital rectal exam are recommended before starting a 5-alpha reductase inhibitor, according to the AUA. Some telehealth platforms accept recent lab results from a primary care physician, while others order labs through national draw networks like Quest or Labcorp, both of which have locations in Manchester, Nashua, and Concord.

Discount Programs and Savings Strategies

Several pathways can lower dutasteride costs in New Hampshire beyond the already-low generic price.

Manufacturer savings cards. GSK previously offered a savings card for brand Avodart, but with the generic widely available, the brand program has limited value. Generic manufacturers do not typically offer patient savings cards. The real savings come from pharmacy-level pricing competition.

Discount card aggregators. GoodRx, RxSaver, and SingleCare list New Hampshire pharmacy prices for generic dutasteride ranging from $8 to $30 per 30-count supply. These are free to use and do not require insurance. The FDA encourages patients to compare prices across pharmacies to minimize out-of-pocket costs.

90-day fills. Many pharmacies and insurance plans offer a lower per-unit cost for 90-day supplies. A 90-day fill of generic dutasteride may cost $20 to $60 total, compared to $25 per month for three separate 30-day fills. Ask your pharmacist or insurance plan if this option is available.

Patient assistance programs. NeedyMeds and RxAssist maintain databases of assistance programs for prescription medications. While dutasteride-specific programs are uncommon given the low generic price, uninsured patients with limited income may qualify for broader pharmacy discount programs offered by chains like Walmart ($4/$10 generic list) or Costco.

Mail-order pharmacies. AARP and Medicare-affiliated mail-order pharmacies sometimes offer the lowest per-unit pricing on generics, including dutasteride. Check your plan's preferred mail-order pharmacy before filling locally.

Side Effects and Monitoring Considerations

Cost alone should not drive prescribing decisions. Dutasteride carries a defined side-effect profile. The FDA-approved label reports the following adverse events from clinical trials: erectile dysfunction (4.7% vs. 1.7% placebo), decreased libido (3.0% vs. 1.4% placebo), ejaculation disorders (1.4% vs. 0.5% placebo), and gynecomastia (1.3% vs. 0.3% placebo).

These rates come from the Phase III CombAT trial (N=4,844) comparing dutasteride, tamsulosin, and combination therapy over four years. Sexual side effects were most common in the first year and declined with continued use. A smaller proportion of men (<2%) reported persistent sexual symptoms after discontinuation, a phenomenon described in case series but not confirmed in large prospective trials.

Dutasteride also suppresses serum PSA by approximately 50% within 3 to 6 months. Clinicians must double the measured PSA value to estimate the true PSA level in men taking dutasteride, a correction that is relevant for prostate cancer screening. The REDUCE trial (N=6,729) found that dutasteride reduced overall prostate cancer incidence by 22.8% compared to placebo over four years but showed a small increase in Gleason 8-10 tumors (0.9% vs. 0.6%), a finding that remains debated.

How to Get Started in New Hampshire

Patients in New Hampshire can obtain dutasteride through three steps. First, schedule an evaluation with a primary care physician, urologist, or licensed telehealth provider. For BPH, this includes symptom assessment (IPSS score), PSA testing, and prostate size estimation. For hair-loss use, a dermatologic history and scalp evaluation are standard.

Second, request generic dutasteride 0.5 mg specifically. Brand Avodart provides no clinical advantage and costs 10 to 12 times more.

Third, compare prices at two or three pharmacies or check a discount aggregator before filling. The difference between $8 and $30 per month may be the difference between the pharmacy across the street and the one down the road. Ask about 90-day pricing to reduce trips and cost per capsule.